2024-06-13T08:55:41.889Z
ASTuTE
ASTuTE
Prostate cancer
Shared decision making using multimodal Artificial Intelligence (MMAI) with digital histopathology for Androgen Deprivation Therapy (ADT) use in men with intermediate risk prostate cancer managed with standard of care radiotherapy.
Shared decision making using multimodal Artificial Intelligence (MMAI) with digital histopathology for Androgen Deprivation Therapy (ADT) use in men with intermediate risk prostate cancer managed with standard of care radiotherapy.
Trial overview
Clinical Area
Radiation Oncology
Disease / Condition
Prostate Cancer
Phase
II
Trial Identifiers
Registration number: ACTRN12623000713695
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385964&isReview=true
GenesisCare Location(s)
Principal Investigator(s)